Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
102,398,919
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
77,162
-
Shares change
-
+68,076
-
Total reported value, excl. options
-
$243,273
-
Value change
-
+$214,440
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$3.15
Significant Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA) as of Q4 2024
7 filings reported holding KTTA - Pasithea Therapeutics Corp. - Common Stock as of Q4 2024.
Pasithea Therapeutics Corp. - Common Stock (KTTA) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77,162 shares
of 102,398,919 outstanding shares and own 0.08% of the company stock.
Largest 7 shareholders include ARMISTICE CAPITAL, LLC (61,000 shares), UBS Group AG (12,868 shares), Tower Research Capital LLC (TRC) (1,886 shares), MORGAN STANLEY (1,000 shares), Royal Bank of Canada (250 shares), JPMORGAN CHASE & CO (150 shares), and BANK OF AMERICA CORP /DE/ (8 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.